Publications
Found 70 results
Author Title Type [ Year] Filters: First Letter Of Last Name is R [Clear All Filters]
Modular plasmonic nanocarriers for efficient delivery of siRNA with spatial and temporal control (749.2). The FASEB Journal. 28:749–2.
.
2014. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. Journal of Controlled Release.
.
2014. A mussel-derived one component adhesive coacervate. Acta biomaterialia. 10:1663–1670.
.
2014. Reprogramming Human Retinal Pigmented Epithelial Cells to Neurons Using Recombinant Proteins. Stem cells translational medicine. 3:1526–1534.
.
2014. Spatiotemporally controlled delivery of biomolecules (1053.5). The FASEB Journal. 28:1053–5.
.
2014. .
2014. .
2014. .
2014. Application of a proapoptotic peptide to intratumorally spreading cancer therapy. Cancer research. 73:1352–1361.
.
2013. De novo design of a tumor-penetrating peptide. Cancer research. 73:804–812.
.
2013. De novo design of a tumor-penetrating peptide. Cancer research. 73:804–812.
.
2013. De novo design of a tumor-penetrating peptide. Cancer research. 73:804–812.
.
2013. Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. Molecular Therapy. 21:2195–2204.
.
2013. STAT1: DNA sequence-dependent binding modulation by phosphorylation, protein: protein interactions and small-molecule inhibition. Nucleic acids research. 41:754–763.
.
2013. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proceedings of the National Academy of Sciences. 110:10753–10758.
.
2013. .
2012.
Neuronal clustering and fasciculation phenotype in Dscam-and Bax-deficient mouse retinas. Journal of Comparative Neurology. 520:1349–1364.
.
2012. Site-specific targeting of antibody activity< i> in vivo mediated by disease-associated proteases. Journal of Controlled Release. 161:804–812.
.
2012. Spontaneous shape reconfigurations in multicompartmental microcylinders. Proceedings of the National Academy of Sciences. 109:16057–16062.
.
2012. TLE1 Is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Molecular Cancer Research. 10:1482–1495.
.
2012.